- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00741065
DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting (DESWT)
February 10, 2010 updated by: Cardiac Regeneration Technologies, LLC
Study purpose: To examine the safety of myocardial regeneration by direct epicardial shock wave therapy in combination with coronary artery bypass grafting.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Direct epicardial shock wave therapy: DESWT will be performed in adjunct to a standard CABG procedure.
Prior to aortic cross clamping, DESWT will be performed using a CardioGold® CG050 (CRT Cardiac Regeneration Technologies, Woodstock, USA / manufactured by MTS-Europe GmbH, Konstanz, Germany) shock wave therapy device and a specially designed handheld applicator under sterile conditions.
Depending on the localisation of the myocardial infarct scar, 290-310 impulses will be applied to the anterior, lateral, or posterior wall.
Shock waves will be generated at 1 or 2 Hz in a non ECG triggered fashion, should DESWT result in significant ventricular arrhythmias, ECG gating will be initiated.
After completion of DESWT, CABG will be continued in a regular fashion.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, 1090
- Clinical Department for Cardiothoracic Surgery, General Hospital Vienna
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female patients above 18 years of age undergoing primary coronary artery bypass grafting.
- Patients have to present with reduced left ventricular function defined as LVEF < 50%.
- Patients have to present with regional left ventricular wall motion abnormalities.
- Patients have to give written informed consent to participate in the study.
Exclusion Criteria:
- Significant concomitant valve disease(except significant valve disease not detected in preoperative cardiac ultrasound that is detected intra-operatively).
- HIV positive patients.
- Hepatitis C positive patients.
- Patients in cardiogenic shock.
- Patients with a contraindication for cardiac MRI.
- Present contraindication for transoesophageal echocardiography (TEE).
- History of significant ventricular arrhythmias, except arrhythmias associated with MI.
- Highly reduced left ventricular function defined as LVEF <30%.
- Present co-morbidity which reduces life expectancy to less than 6 months.
- Presence of ventricular thrombus.
- Presence of a cardiac tumor.
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Safety, Adverse Events
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Michael Grimm, Prof. MD, Vienna General Hospital, Clinical department for Cardiothoracic Surgery, Währinger Gürtel 18-20,1090 Vienna, Austria
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Anticipated)
June 1, 2009
Study Completion (Anticipated)
February 1, 2010
Study Registration Dates
First Submitted
August 25, 2008
First Submitted That Met QC Criteria
August 25, 2008
First Posted (Estimate)
August 26, 2008
Study Record Updates
Last Update Posted (Estimate)
February 11, 2010
Last Update Submitted That Met QC Criteria
February 10, 2010
Last Verified
February 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DESWT,Version:02; May 21,2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reduced Left Ventricular Function Defined as LVEF < 50%
-
University Hospital of FerraraRecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Left Bundle-Branch Block | Bundle-Branch Block | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Atrioventricular Block | Heart Failure, Systolic | Ventricular Arrythmia | Heart Failure,Congestive | Bradyarrhythmia | Heart Arrhythmia | Reduced... and other conditionsItaly
Clinical Trials on Direct Epicardial Shock Wave Therapy
-
Rodrigo Marcel Valentim da SilvaUniversidade Federal do Rio Grande do NorteCompletedPain | Muscle Tonus
-
Northern Orthopaedic Division, DenmarkCompletedChronic Inflammatory Disorder
-
Yuzuncu Yıl UniversityCompleted
-
Isfahan University of Medical SciencesUnknownPlantar FasciitisIran, Islamic Republic of
-
Yonsei UniversityUnknownPost-Stroke Elbow SpasticityKorea, Republic of
-
Carol Davila University of Medicine and PharmacyActive, not recruitingStroke, Ischemic | Stroke Hemorrhagic | Balance; Distorted | Spasticity as Sequela of Stroke | Spastic GaitRomania
-
Oslo University HospitalUnknownShoulder Impingement Syndrome | Subacromial Shoulder PainNorway
-
Saglik Bilimleri UniversitesiEnrolling by invitationStroke | Spasticity as Sequela of StrokeTurkey
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
Medical University of ViennaUnknown